BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Washida N, Inoue S, Kasai T, Shinozuka K, Hosoya K, Morimoto K, Wakino S, Hayashi K, Itoh H. Impact of Switching From Darbepoetin Alfa to Epoetin Beta Pegol on Iron Utilization and Blood Pressure in Peritoneal Dialysis Patients: Switching from Darbepoietin Alfa to Epoetin Beta Pegol. Ther Apher Dial 2015;19:450-6. [DOI: 10.1111/1744-9987.12306] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Koibuchi K, Miyagi M, Arai T, Aoki T, Aikawa A, Sakai K. Comparing the efficacy of continuous erythropoietin receptor activator and darbepoetin Alfa treatments in Japanese patients with chronic kidney disease during the predialysis period: A propensity-matched analysis: Hb maintenance by ESAs in predialysis. Nephrology 2015;20:22-8. [DOI: 10.1111/nep.12641] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yasukawa M, Arai S, Nagura M, Kido R, Asakawa S, Hirohama D, Yamazaki O, Tamura Y, Fujimaki M, Kobayashi S, Mimaki M, Kodama H, Uchida S, Fujigaki Y, Shibata S. Selenium associates with response to erythropoiesis-stimulating agents in hemodialysis patients. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.04.009] [Reference Citation Analysis]
3 Fischbach M, Wühl E, Reigner SCM, Morgan Z, Schaefer F. Efficacy and Long-Term Safety of C.E.R.A. Maintenance in Pediatric Hemodialysis Patients with Anemia of CKD. Clin J Am Soc Nephrol 2018;13:81-90. [PMID: 29097481 DOI: 10.2215/CJN.03570417] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Matsumura K, Okumiya T, Sugiura T, Takahashi N, Yamamoto Y, Kikuchi S, Fujii K, Otagaki M, Shiojima I. Shortened red blood cell age in patients with end-stage renal disease who were receiving haemodialysis: a cross-sectional study. BMC Nephrol 2020;21:418. [PMID: 32993543 DOI: 10.1186/s12882-020-02078-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Kuwahara M, Arai Y, Takehara E, Sasaki Y, Yoshimine T, Kusaka K, Shikuma S, Akita W, Uchida S. Early response to erythropoiesis-stimulating agents in non-dialysis chronic kidney disease patients. Clin Exp Nephrol 2016;20:585-94. [PMID: 26511877 DOI: 10.1007/s10157-015-1188-x] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]